ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business trends

Japan's vaccine makers target dengue, cholera and malaria

Biotech-driven inoculations due to reach market starting in 2020

Japan's Takeda Pharmaceutical is developing a vaccine to combat dengue fever in Latin America and Asia.   © Reuters

TOKYO -- Japanese drug developers are preparing novel vaccines for the market, designed to combat the spread of dengue fever, cholera and malaria by using the latest in biopharmaceutical technology.

Takeda Pharmaceutical will apply for approval of its dengue fever vaccine next year, hoping to launch the product in 2020. The company will supply the vaccine in Latin American and Asian countries where many of the 3.9 billion people at risk of contracting the disease live.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more